How does inflammation mask iron deficiency on ferritin?

Last reviewed 29 April 2026

This entry is part of the Nutri Tailor Health Reference Library — cited research on supplements, nutrients and adjacent areas of health.

Summary

Ferritin is an acute-phase reactant: it rises during infection, inflammation, and chronic inflammatory conditions independent of true iron stores. WHO 2020 strongly recommends measuring CRP alongside ferritin, with a conditional adjusted threshold of 70 µg/L (rather than 15 µg/L) when CRP is above 5 mg/L. Two patterns must be distinguished: absolute iron deficiency masked by superimposed inflammation, and functional iron deficiency or anaemia of inflammation.

How it works

The combined effect: serum iron and transferrin saturation fall, while serum ferritin rises, even when functional iron supply to erythropoiesis is reduced. This mechanism is well characterised in chronic inflammatory conditions including obesity, chronic kidney disease, liver disease, heart failure, and inflammatory bowel disease. Two patterns to distinguish: Pattern 1 (absolute iron deficiency with superimposed inflammation): ferritin in low-normal or normal range; transferrin saturation low (typically below 20%); total iron-binding capacity high or normal; soluble transferrin receptor (sTfR) elevated; CRP/AGP elevated. Pattern 2 (functional iron deficiency, anaemia of inflammation): ferritin elevated; transferrin saturation low; TIBC LOW (key distinguishing feature); sTfR usually normal; hepcidin elevated.

Safety profile

Iron supplementation in functional iron deficiency or anaemia of inflammation may be ineffective or counterproductive without addressing the underlying inflammatory process. sTfR is not yet universally available and is not standardised across assays. Hepcidin assays are not routinely available clinically. Iron supplementation in iron-replete individuals carries risk; iron status testing is appropriate before supplementation outside well-defined high-risk groups.

Special populations

Obesity: chronic low-grade inflammation requires inflammation-adjusted thresholds. Inflammatory bowel disease: BSG 2021 addresses; parenteral iron often preferred in active disease. Heart failure: functional iron deficiency is common and clinically relevant. Heavy menstrual bleeding with active endometriosis, fibroids, or pelvic inflammation: iron deficiency can be masked by inflammation-elevated ferritin. Recurrent infection or recent acute infection: acute-phase response can elevate ferritin for weeks.

Interactions

Inflammation-driven hepcidin elevation explains why oral iron is often ineffective in active inflammatory conditions. IV iron bypasses intestinal absorption and is BSG 2021 supported in moderate-to-severe IBD-related IDA, in those intolerant of oral iron, and in select clinical contexts. CRP-aware ferritin interpretation alongside iron status is the standard pathway.

Interaction	Issue	Guidance	Citation
Iron and calcium	Calcium reduces non-haem iron absorption	Separate iron supplements from calcium-containing meals by around 2 hours	NIH ODS — Iron Fact Sheet for Health Professionals

Guideline positions

Standard WHO 2020 ferritin thresholds: below 15 µg/L (apparently healthy adults, including non-pregnant women); below 12 µg/L (children under 5); below 30 µg/L (children) or below 70 µg/L (adults) when inflammation is present (CRP above 5 mg/L or AGP above 1 g/L). UK NICE CKS: below 30 µg/L; or 30-100 µg/L if clinical symptoms or other markers (e.g. low transferrin saturation) support iron deficiency. AGA 2020: below 45 µg/L threshold for adults (population was at higher risk of inflammation than WHO healthy-population baseline). Cappellini, Musallam and Taher 2020 ASH Education Program review provides detailed mechanistic and clinical guidance for chronic inflammatory conditions.

Practical framework

Standard biomarker panel: serum ferritin (primary screening test but acute-phase elevated); transferrin saturation (less affected by acute-phase response, below 20% suggests iron deficiency); TIBC (elevated in absolute iron deficiency, low in anaemia of inflammation); sTfR (elevated in iron-restricted erythropoiesis irrespective of inflammation); CRP (inflammation marker, above 5 mg/L cut-off in WHO 2020); AGP (chronic inflammation marker, above 1 g/L cut-off in WHO 2020). After iron repletion, retest at 4 weeks and 3 months per BSG 2021. This is a summary of published research, not personal health advice. Discuss any health or supplement decisions with a qualified healthcare professional, particularly during ongoing care, pregnancy, or with chronic conditions.

Common misconceptions

Claim: oral iron will resolve anaemia of inflammation. In Pattern 2 (functional iron deficiency, anaemia of inflammation), oral iron is generally less effective; addressing the underlying inflammation is the primary intervention; IV iron may be considered in selected cases. Physiological-threshold studies (Mei 2021 NHANES; Addo 2025 multinational; Pasricha 2021 Lancet Haematol) suggest iron-restricted erythropoiesis onset at roughly 22-25 µg/L in non-pregnant women and children when measured by sTfR and haemoglobin inflection points, higher than the historical WHO 15 µg/L cut-off.

Who this matters for

This entry is relevant for the following groups, conditions, and medication contexts:

Pregnancy
Breastfeeding
Adults over 65
Post-menopause
Inflammatory bowel disease
Kidney impairment
Liver impairment
People taking levothyroxine

Recent updates

2 May 2026 — Source-flag triage cleared all needs_review flags; entry now passes lint; flipped v4_complete = true.
29 April 2026 — v3.1 -> v4 content retrofit. (1) bottom_line: 1229 chars to 65 words. (2) structured_sections from 11 keys (evidence, mechanism, special_populations, studied_applications, biomarkers_in_studies, thresholds_in_studies, limitations_and_cautions, monitoring_recommendations, outcomes_measured_in_trials, two_patterns_to_distinguish, clinical_examples_for_interpretation) to 8 canonical (mechanism, safety_profile, special_populations, interactions, guideline_anchors, practical_framework, common_misconceptions, cross_references). two_patterns_to_distinguish folded into mechanism body. biomarkers_in_studies + monitoring_recommendations folded into practical_framework. thresholds_in_studies folded into guideline_anchors body. clinical_examples_for_interpretation folded into special_populations body. (3) ~6 em-dashes (—) and 1 en-dash (–) cleaned up. (4) Disclaimer updated. (5) population_tags: 8. medication_interactions: 1. supplement_interactions: 1. (6) IMPORTANT: v4_complete NOT FLIPPED. Lint passes content checks (0 dashes, 65 words BL, all canonical sections) but 4 sources have needs_review=true: Cappellini 2020 ASH Education Program review, AGA 2020 (Ko et al), Addo 2025 Lancet Glob Health multinational, Mei 2021 NHANES. All 4 reviewer flags are bibliographic precision concerns ("PMID/DOI pending primary PubMed verification before next publishability sign-off") not content-validity concerns; the substantive claims are anchored elsewhere via citing literature.
28 April 2026 — PLS rewritten 2056->4900 chars. Acute-phase reactant mechanism, WHO 2020/BSG 2021/AGA 2020 guidance, two patterns (masked absolute vs functional/AoI), clinical examples (HMB, IBD, CKD, obesity, pregnancy), additional markers. No inline PMIDs.

Sources

World Health Organization 2020. WHO guideline on use of ferritin concentrations to assess iron status in individuals and populations. World Health Organization (Geneva).
Fertrin KY 2020. Diagnosis and management of iron deficiency in chronic inflammatory conditions (CIC): is too little iron making your patient sick?. Hematology Am Soc Hematol Educ Program. PMID: 33275757 · DOI: 10.1182/hematology.2020000132
Snook J, Bhala N, Beales ILP, Cannings D, Kightley C, Logan RPH, Pritchard DM, Sidhu R, Surgenor S, Thomas W, Verma AM 2021. British Society of Gastroenterology guidelines for the management of iron deficiency anaemia in adults. Gut. PMID: 34497146 · DOI: 10.1136/gutjnl-2021-325210
Ko CW, Siddique SM, Patel A, Harris A, Sultan S, Altayar O, Falck-Ytter Y 2020. AGA Clinical Practice Guidelines on the Gastrointestinal Evaluation of Iron Deficiency Anemia. Gastroenterology. PMID: 32810434 · DOI: 10.1053/j.gastro.2020.06.046
Addo OY, Mei Z, Jefferds MED, et al 2025. Physiologically based serum ferritin thresholds for iron deficiency among women and children from Africa, Asia, Europe, and central America: a multinational comparative study. Lancet Glob Health. PMID: 40288394 · DOI: 10.1016/s2214-109x(25)00009-9
Mei Z, Addo OY, Jefferds MED, et al 2021. Physiologically based serum ferritin thresholds for iron deficiency in children and non-pregnant women: a US NHANES study. Lancet Haematol. PMID: 34329578 · DOI: 10.1016/s2352-3026(21)00168-x
NIH Office of Dietary Supplements. NIH Office of Dietary Supplements — Iron Fact Sheet for Health Professionals. NIH Office of Dietary Supplements (US government).

Back to Iron overview